Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium (EC-MPS) or mycophenolate mofetil (MMF) at 12 months post-transplant

被引:0
|
作者
Segovia, Javier [1 ]
Gerosa, Gino
Almenar, Luis [2 ]
Livi, Ugolino [3 ]
Vigano, Mario [4 ]
Arizon, Jose Maria [5 ]
Yonan, Nizar [6 ]
机构
[1] Hosp Univ Puerta Hierro, Unidad Transplante Cardiac, Madrid, Spain
[2] Hosp La Fe, E-46009 Valencia, Spain
[3] Univ Hosp, Dept Cardiopulm Sci, Udine, Italy
[4] Univ Hosp, Cardiosurg Div, Pavia, Italy
[5] Hosp Reina Sofia, Unidad Transplante Cardiac, Cordoba, Spain
[6] Wythenshawe Hosp, Cardiothorac Transplantat Ctr, Manchester M23 9LT, Lancs, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:6 / 6
页数:1
相关论文
共 50 条
  • [31] LONG-TERM SAFETY OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT RECIPIENTS
    Neumayer, Hans H.
    [J]. NEPHROLOGY, 2005, 10 : A213 - A213
  • [32] Significant pharmacokinetic differences between mycophenolate mofetil and enteric-coated mycophenolate sodium (EC-MPS) in stable renal transplant patients treated with tacrolimus without steroids.
    Puig, J. M.
    Mir, M.
    Marin, M.
    Ferrer, M.
    Barrios, C.
    Barbosa, F.
    Vazquez, S.
    Rodriguez, E.
    Lloveras, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 349 - 349
  • [33] Influence of the Proton-Pump Inhibitor Pantoprazole on Mycophenolic Acid Pharmacokinetics: A Comparison of Mycophenolate Mofetil (MMF) and Enteric-Coated Mycophenolate Sodium (EC-MPS)
    Rupprecht, K.
    Kees, F.
    Schmidt, Ch.
    Raspe, A.
    Bucher, M.
    Schweda, F.
    Shipkova, M.
    Faerber, L.
    Fischer, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 510 - 510
  • [34] Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic®) is safe in kidney transplant patients
    Salvadori, M.
    Holzer, H.
    Civati, G.
    Sollinger, H.
    Lien, B.
    Tomlanovich, S.
    Bertoni, E.
    Seifu, Y.
    Marrast, A. -C.
    [J]. CLINICAL NEPHROLOGY, 2006, 66 (02) : 112 - 119
  • [35] Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil
    Tedesco-Silva, H
    Bastien, MC
    Choi, L
    Felipe, C
    Campestrini, J
    Picard, F
    Schmouder, R
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 852 - 855
  • [36] Economic impact of gastrointestinal medication reduction after conversion from mycophenolate mofetil (MMT) to enteric-coated mycophenolate sodium (EC-MPS).
    Bolin, Paul
    Parker, Karen
    Gerkin, Susan
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A31 - A31
  • [37] IMPROVED HEALTH RELATED QUALITY OF LIFE (HRQOL) IN RENAL TRANSPLANT PATIENTS SUFFERING FROM GASTROINTESTINAL (GI) COMPLAINTS WHEN CONVERTED FROM MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS)
    Chan, L.
    Mulgaonkar, S.
    Schiavelli, R.
    Ambuehl, P.
    Arns, W.
    Walker, R.
    [J]. NEPHROLOGY, 2005, 10 : A215 - A216
  • [38] Interest of conversion from mycophenolate mofetil (MMF) to enteric coated mycophenolate sodium EC-MPS in stable renal transplanted children.
    Meneses, Rejane de Paula
    Kotsifas, Cecilia Hallush
    Olandoski, Karen Previdi
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 367 - 367
  • [39] Economic impact of gastrointestinal medication reduction following conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) associated with improvement in quality of life (QOL)
    Parker, Karen R.
    Bolin, Paul
    Gerkin, Susan R.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 350 - 350
  • [40] Addition of enteric coated sodium mycophenolate (EC-MPS) for steroid withdrawal in maintenance renal transplant patients
    Citterio, Franco
    Sandrini, Silvio
    Altieri, Paolo
    Romagnoli, Jacopo
    Tondolo, Vincenzo
    Vinaccia, Vincenza
    Corbetta, Giuseppe
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 124 - 124